Jan K. Blusztajn, PhD
Professor
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine
Other Pathology

PhD, Massachusetts Institute of Technology
MS, University of Warsaw



Jan K. Blusztajn, PhD is a Professor of Pathology in the Department of Pathology & Laboratory Medicine at the Chobanian and Avedisian School of Medicine. Dr. Blusztajn received his PhD in Neural and Endocrine Regulation from the Massachusetts Institute of Technology. Dr. Blusztajn's research is in prenatal programming of brain development and aging by essential nutrient availability during gestation.

Research Professor
Boston University Chobanian & Avedisian School of Medicine
Psychiatry


Member
Boston University
BU-BMC Cancer Center


Investigator
Framingham Heart Study


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Member
Boston University
Genome Science Institute


Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences




Age-Associated Lipidomic Changes in Alzheimer's Disease
02/01/2019 - 06/30/2024 (Multi-PI)
PI: Jan K. Blusztajn, PhD
NIH/National Institute on Aging
1RF1AG057768-01A1

MicroRNAs as Diagnostic and Prognostic Biomarker of Alzheimer's Disease
09/01/2022 - 08/18/2023 (Subcontract PI)
Rhode Island Hospital NIH NIA
1RF1AG078299-01

Regulation of the hippocampal DNA methylation clock by choline nutrition in a mouse model of Alzheimer's disease
08/01/2018 - 06/30/2021 (PI)
NIH/National Institute on Aging
5R21AG059195-02

BMP9 as a juvenile protective factor in cognitive aging
06/01/2014 - 05/31/2020 (PI)
NIH/National Institute on Aging
5R01AG045031-05

Age-Associated Lipidomic Changes in Alzheimer's Disease
09/30/2017 - 01/31/2019 (Multi-PI)
PI: Jan K. Blusztajn, PhD
NIH/National Institute on Aging
1R56AG057768-01

Personnel Agreement for Research Services of Jan Blusztajn
09/01/2017 - 08/31/2018 (PI)
VA Boston Healthcare System


Personnel Agreement for Research Services of Jan Blusztajn
09/01/2017 - 08/31/2018 (PI)
VA Boston Healthcare System


Personnel Agreement for Research Services of Jan Blusztajn
10/01/2013 - 06/30/2017 (Key Person)
PI: Daniel G. Remick Jr., MD
VA Boston Healthcare System


Personnel Agreement for Research Services of Jan Blusztajn
10/01/2013 - 06/30/2017 (Key Person)
PI: Daniel G. Remick Jr., MD
VA Boston Healthcare System


Personnel agreement for research services of Erica Langley
04/01/2014 - 09/14/2014 (PI)
VA Boston Healthcare System


Showing 10 of 14 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2022 MicroRNAs as Diagnostic and Prognostic Biomarker of Alzheimer's Disease 7RF1AG078299-02
2021 Age-Associated Lipidomic Changes in Alzheimer's Disease 3RF1AG057768-01A1S1 4
2019 Age-Associated Lipidomic Changes in Alzheimer's Disease 1RF1AG057768-01A1 4
2019 Regulation of the hippocampal epigenetic DNA methylation clock by choline nutrition in a mouse model of Alzheimer's disease 5R21AG059195-02
2018 Regulation of the hippocampal epigenetic DNA methylation clock by choline nutrition in a mouse model of Alzheimer's disease 1R21AG059195-01A1
2018 BMP9 as a juvenile protective factor in cognitive aging 5R01AG045031-05 11
2017 Age-Associated Lipidomic Changes in Alzheimer's Disease 1R56AG057768-01 7
2017 BMP9 as a juvenile protective factor in cognitive aging 3R01AG045031-04S1 11
2017 BMP9 as a juvenile protective factor in cognitive aging 5R01AG045031-04 11
2016 BMP9 as a juvenile protective factor in cognitive aging 5R01AG045031-03 11
Showing 10 of 67 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bellio TA, Laguna-Torres JY, Campion MS, Chou J, Yee S, Blusztajn JK, Mellott TJ. Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Aß42 deposition in AppNL-G-F Alzheimer's disease model mice. PLoS One. 2024; 19(2):e0297289.View Related Profiles. PMID: 38315685; PMCID: PMC10843108; DOI: 10.1371/journal.pone.0297289;
     
  2. Obeid R, Schön C, Derbyshire E, Jiang X, Mellott TJ, Blusztajn JK, Zeisel SH. A Narrative Review on Maternal Choline Intake and Liver Function of the Fetus and the Infant; Implications for Research, Policy, and Practice. Nutrients. 2024 Jan 15; 16(2).View Related Profiles. PMID: 38257153; PMCID: PMC10820518; DOI: 10.3390/nu16020260;
     
  3. Yuan J, Liu X, Liu C, Ang AF, Massaro J, Devine SA, Auerbach SH, Blusztajn JK, Au R, Jacques PF. Is dietary choline intake related to dementia and Alzheimer's disease risks? Results from the Framingham Heart Study. Am J Clin Nutr. 2022 Nov; 116(5):1201-1207.View Related Profiles. PMID: 37208066; PMCID: PMC9630864; DOI: 10.1093/ajcn/nqac193;
     
  4. Blusztajn JK, Aytan N, Rajendiran T, Mellott TJ, Soni T, Burant CF, Serrano GE, Beach TG, Lin H, Stein TD. Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease. J Alzheimers Dis. 2023; 95(4):1623-1634.View Related Profiles. PMID: 37718815; PMCID: PMC10911245; DOI: 10.3233/JAD-230543;
     
  5. Blusztajn JK, Slack BE. Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease. J Alzheimers Dis. 2023; 93(4):1285-1289.View Related Profiles. PMID: 37182883; PMCID: PMC10885637; DOI: 10.3233/JAD-230061;
     
  6. Zhang Z, Na H, Gan Q, Tao Q, Alekseyev Y, Hu J, Yan Z, Yang JB, Tian H, Zhu S, Li Q, Rajab IM, Blusztajn JK, Wolozin B, Emili A, Zhang X, Stein T, Potempa LA, Qiu WQ. Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease? Aging Cell. 2021 11; 20(11):e13501.View Related Profiles. PMID: 34687487; PMCID: PMC8590103; DOI: 10.1111/acel.13501;
     
  7. Kanach C, Blusztajn JK, Fischer A, Delalle I. MicroRNAs as Candidate Biomarkers for Alzheimer's Disease. Noncoding RNA. 2021 Feb 01; 7(1).View Related Profiles. PMID: 33535543; PMCID: PMC7930943; DOI: 10.3390/ncrna7010008;
     
  8. Anderson KE, Bellio TA, Aniskovich E, Adams SL, Blusztajn JK, Delalle I. The Expression of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) in Hippocampal Arterioles Declines During Progression of Alzheimer's Disease. Cereb Cortex Commun. 2020; 1(1):tgaa031.View Related Profiles. PMID: 32974611; PMCID: PMC7497413; DOI: 10.1093/texcom/tgaa031;
     
  9. Wallace TC, Blusztajn JK, Caudill MA, Klatt KC, Zeisel SH. Choline: The Neurocognitive Essential Nutrient of Interest to Obstetricians and Gynecologists. J Diet Suppl. 2020; 17(6):733-752. PMID: 31385730
     
  10. Conner SC, Benayoun L, Himali JJ, Adams SL, Yang Q, DeCarli C, Blusztajn JK, Beiser A, Seshadri S, Delalle I. Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts. J Alzheimers Dis. 2019; 68(1):357-365.View Related Profiles. PMID: 30775993; PMCID: PMC6481535; DOI: 10.3233/JAD-180977;
     
Showing 10 of 173 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 170 publications over 42 distinct years, with a maximum of 11 publications in 2008

YearPublications
19801
19811
19821
19834
19841
19854
19868
19877
19881
19898
19906
19912
19926
19935
19946
19955
19964
19977
19986
19995
20009
20014
20024
20033
20042
20053
20063
20076
200811
20104
20114
20122
20132
20142
20162
20176
20185
20192
20201
20212
20233
20242

Contact for Mentoring:

72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Blusztajn's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department